| Dr Megan Kate Greenya, AUD | |
|
446 Old Newport Blvd, 100, Newport Beach, CA 92663-4246 | |
| (949) 631-4327 | |
| (949) 631-2030 |
| Full Name | Dr Megan Kate Greenya |
|---|---|
| Gender | Female |
| Speciality | Qualified Audiologist |
| Experience | 18 Years |
| Location | 446 Old Newport Blvd, Newport Beach, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487673570 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 23002764A (Indiana) | Primary |
| 231H00000X | Audiologist | AU 2455 (California) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Community Care Network Inc | 3678737012 | 360 |
News Archive
Novo Nordisk Inc., a world leader in diabetes care, announced that it has awarded funds to support scholarships and capital improvements to diabetes summer camps at fifteen locations nationwide. In support of their dedication to meeting the needs of children with diabetes, the grants will help the camps provide financial assistance programs to campers and improve facilities for the campers' use.
APP Pharmaceuticals, Inc., a Fresenius Kabi Company, announced today that it will launch both Imipenem and Cilastatin for Injection, USP and Meropenem for Injection, USP in the United States. APP will begin shipping Meropenem for Injection the week of February 13, 2012 with Imipenem and Cilastatin for Injection scheduled to ship in the next three to five weeks.
The American Academy of Neurology (AAN) is awarding the 2010 Sheila Essey Award-An Award for ALS Research to Clive Svendsen, PhD, with the Cedars-Sinai Regenerative Medicine Institute in Los Angeles, CA. Svendsen will receive the award during the AAN's 62nd Annual Meeting in Toronto, held April 10 through April 17, 2010.
OncoVista Innovative Therapies, Inc., reported that the AdnaTest BreastCancer Select & Detect kit, manufactured by AdnaGen AG (Langenhagen, Germany), is now available for research as well as for pay-out-of-pocket patients in the Czech Republic and Slovakia.
Parent Project Muscular Dystrophy, a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne) awarded University of Washington a $148,000 grant to continue the functional analysis of spectrin-like repeats in dystrophin.
› Verified 4 days ago
| Provider Name | Munster Medical Research Foundation Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1982653044 PECOS PAC ID: 8123913183 Enrollment ID: O20040623000905 |
News Archive
Novo Nordisk Inc., a world leader in diabetes care, announced that it has awarded funds to support scholarships and capital improvements to diabetes summer camps at fifteen locations nationwide. In support of their dedication to meeting the needs of children with diabetes, the grants will help the camps provide financial assistance programs to campers and improve facilities for the campers' use.
APP Pharmaceuticals, Inc., a Fresenius Kabi Company, announced today that it will launch both Imipenem and Cilastatin for Injection, USP and Meropenem for Injection, USP in the United States. APP will begin shipping Meropenem for Injection the week of February 13, 2012 with Imipenem and Cilastatin for Injection scheduled to ship in the next three to five weeks.
The American Academy of Neurology (AAN) is awarding the 2010 Sheila Essey Award-An Award for ALS Research to Clive Svendsen, PhD, with the Cedars-Sinai Regenerative Medicine Institute in Los Angeles, CA. Svendsen will receive the award during the AAN's 62nd Annual Meeting in Toronto, held April 10 through April 17, 2010.
OncoVista Innovative Therapies, Inc., reported that the AdnaTest BreastCancer Select & Detect kit, manufactured by AdnaGen AG (Langenhagen, Germany), is now available for research as well as for pay-out-of-pocket patients in the Czech Republic and Slovakia.
Parent Project Muscular Dystrophy, a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne) awarded University of Washington a $148,000 grant to continue the functional analysis of spectrin-like repeats in dystrophin.
› Verified 4 days ago
| Provider Name | Community Care Network Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1457610487 PECOS PAC ID: 3678737012 Enrollment ID: O20120614000331 |
News Archive
Novo Nordisk Inc., a world leader in diabetes care, announced that it has awarded funds to support scholarships and capital improvements to diabetes summer camps at fifteen locations nationwide. In support of their dedication to meeting the needs of children with diabetes, the grants will help the camps provide financial assistance programs to campers and improve facilities for the campers' use.
APP Pharmaceuticals, Inc., a Fresenius Kabi Company, announced today that it will launch both Imipenem and Cilastatin for Injection, USP and Meropenem for Injection, USP in the United States. APP will begin shipping Meropenem for Injection the week of February 13, 2012 with Imipenem and Cilastatin for Injection scheduled to ship in the next three to five weeks.
The American Academy of Neurology (AAN) is awarding the 2010 Sheila Essey Award-An Award for ALS Research to Clive Svendsen, PhD, with the Cedars-Sinai Regenerative Medicine Institute in Los Angeles, CA. Svendsen will receive the award during the AAN's 62nd Annual Meeting in Toronto, held April 10 through April 17, 2010.
OncoVista Innovative Therapies, Inc., reported that the AdnaTest BreastCancer Select & Detect kit, manufactured by AdnaGen AG (Langenhagen, Germany), is now available for research as well as for pay-out-of-pocket patients in the Czech Republic and Slovakia.
Parent Project Muscular Dystrophy, a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne) awarded University of Washington a $148,000 grant to continue the functional analysis of spectrin-like repeats in dystrophin.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Megan Kate Greenya, AUD 8558 Broadway, Merrillville, IN 46410-7032 Ph: (219) 392-7084 | Dr Megan Kate Greenya, AUD 446 Old Newport Blvd, 100, Newport Beach, CA 92663-4246 Ph: (949) 631-4327 |
News Archive
Novo Nordisk Inc., a world leader in diabetes care, announced that it has awarded funds to support scholarships and capital improvements to diabetes summer camps at fifteen locations nationwide. In support of their dedication to meeting the needs of children with diabetes, the grants will help the camps provide financial assistance programs to campers and improve facilities for the campers' use.
APP Pharmaceuticals, Inc., a Fresenius Kabi Company, announced today that it will launch both Imipenem and Cilastatin for Injection, USP and Meropenem for Injection, USP in the United States. APP will begin shipping Meropenem for Injection the week of February 13, 2012 with Imipenem and Cilastatin for Injection scheduled to ship in the next three to five weeks.
The American Academy of Neurology (AAN) is awarding the 2010 Sheila Essey Award-An Award for ALS Research to Clive Svendsen, PhD, with the Cedars-Sinai Regenerative Medicine Institute in Los Angeles, CA. Svendsen will receive the award during the AAN's 62nd Annual Meeting in Toronto, held April 10 through April 17, 2010.
OncoVista Innovative Therapies, Inc., reported that the AdnaTest BreastCancer Select & Detect kit, manufactured by AdnaGen AG (Langenhagen, Germany), is now available for research as well as for pay-out-of-pocket patients in the Czech Republic and Slovakia.
Parent Project Muscular Dystrophy, a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne) awarded University of Washington a $148,000 grant to continue the functional analysis of spectrin-like repeats in dystrophin.
› Verified 4 days ago
Adrienne Klyne Waninger, AU.D Audiologist Medicare: Accepting Medicare Assignments Practice Location: 500 Old Newport Blvd Ste 101, Newport Beach, CA 92663 Phone: 949-642-7935 Fax: 949-642-2950 | |
Howard T Mango, Audiologist Medicare: Accepting Medicare Assignments Practice Location: 500 Old Newport Blvd, Ste 101, Newport Beach, CA 92663 Phone: 949-642-7935 Fax: 949-642-2950 | |
Katherine Elizabeth Slezewick, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 500 Old Newport Blvd Ste 101, Newport Beach, CA 92663 Phone: 949-642-7935 Fax: 949-642-2950 | |
Monica Paige Muncy, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 500 Old Newport Blvd Ste 101, Newport Beach, CA 92663 Phone: 949-642-7935 Fax: 949-642-2950 | |
Hannah C Williams, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 500 Old Newport Blvd, Suite 101, Newport Beach, CA 92663 Phone: 949-642-7935 Fax: 949-642-2950 | |
Blake B Wimmer, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 500 Old Newport Blvd Ste 101, Newport Beach, CA 92663 Phone: 949-642-7925 Fax: 949-642-2950 | |
Christine Mai-vy Nguyen, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 500 Old Newport Blvd Ste 101, Newport Beach, CA 92663 Phone: 949-642-7935 Fax: 949-642-2950 |